Research Affairs: 2018 NIH Notices http://myllu.llu.edu/syncall/communityhome/?communityId=6088 en-us Fri, 10 May 2024 07:08:28 -0700 SyncAll RSS 1.0 6088:35687 <![CDATA[New guidelines for NIH and AHRQ Career Development Award Applications]]> NIH and AHRQ NIH and AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Career Development Award Applications

“The upcoming updates clarify the current application instructions and review criteria by replacing the term "scientific premise" with "the rigor of the prior research" and adding instruction and review language so that "the rigor of the prior research" is addressed under Significance and Approach. In addition, the updates include new policy requirements for the NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects (NOT-OD-18-116). The exemption language within the review criteria for the Protections for Human Subjects will be updated in preparation for the implementation of the Revised Common Rule.”

Detail information: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-229.html

For additional information contact Pre Award – rapreaward@llu.edu or x44589

]]> Tue, 02 Oct 2018 14:29:51 -0700 6088:35690 <![CDATA[New guidelines for NIH and AHRQ Career Development Award Applications]]> NIH and AHRQ NIH and AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Career Development Award Applications

“The upcoming updates clarify the current application instructions and review criteria by replacing the term "scientific premise" with "the rigor of the prior research" and adding instruction and review language so that "the rigor of the prior research" is addressed under Significance and Approach. In addition, the updates include new policy requirements for the NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects (NOT-OD-18-116). The exemption language within the review criteria for the Protections for Human Subjects will be updated in preparation for the implementation of the Revised Common Rule.”

Detail information: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-229.html

For additional information contact Pre Award – rapreaward@llu.edu or x44589

]]> Tue, 02 Oct 2018 00:00:00 -0700 6088:35688 <![CDATA[Funding Opportunities]]> NIH / American Heart Association NIH - Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional):  “This Funding Opportunity Announcement (FOA) invites applications that seek to understand strategies to reduce disparities in the uptake of evidence-based screening (e.g. screening recommendations proven to be effective based on rigorous systematic review of scientific evidence by authoritative committees) across the adult lifespan.  In this program announcement, screening is defined as a preventive service focused on detection of an undiagnosed disease in asymptomatic populations. Research supported by this initiative should enhance the screening process related to use: (1) in diverse populations, (2) in diverse clinical and community settings, and/or (3) with traditional, non-traditional and/or allied health care providers.”

Detail information: https://grants.nih.gov/grants/guide/pa-files/PA-18-932.html

 

American Heart Association:  Now accepting Letters of Intent for their “Collaborative Science Award,” Established Investigator Award,” and “Innovative Project Award.”

https://professional.heart.org/professional/ResearchPrograms/ApplicationInformation/UCM_320496_Application-Deadlines.jsp

For additional information contact Pre Award – rapreaward@llu.edu or x44589

]]> Tue, 02 Oct 2018 14:32:07 -0700 6088:33060 <![CDATA[New PHS FORMS-E for use when applying for grants involving Human subjects and/or clinical trials respectively]]> Wesley James The NIH has begun reissuing all their parent announcements with new Funding Opportunity Announcements (FOA) numbers to include FORMS-E packages. 

Effective on and/or after January 25, 2018 the NIH has standardized the way you display human subject information for human studies and clinical trials. The new FOA numbers are:

R01:

  • PA-18-484 for NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed). This is a reissue of PA-16-160 for due dates on or after January 25, 2018.
  • PA-18-345for NIH Research Project Grant (Parent R01 Clinical Trial Required).

R21:

  • PA-18-489 for NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed).This is a reissue of PA-16-161 for due dates on or after January 25, 2018.
  • PA-18-344 for NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required).

For more information on policy changes, instructions, and revised forms, click on:

Plan early so that you give yourself enough time to get familiar with the new forms requirements. For more information, contact Pre Award, rapreaward@llu.edu or x44589.

]]> Thu, 04 Jan 2018 16:29:21 -0800 6088:32688 <![CDATA[NIH will Make the Project Outcomes Section of all Interim and Final RPPRs Submitted on or After October 1, 2017 Available via the NIH RePORTER ]]> NIH notices The National Institutes of Health (NIH) intends to publish the Project Outcomes Section of all Final and Interim Research Performance Progress Reports (RPPRs) submitted on or after October 1, 2017 and make them available to the general public via the NIH RePORTER.

More information can be found at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-103.html

]]> Wed, 22 Nov 2017 09:52:55 -0800 6088:32687 <![CDATA[NIH Request for Information on Developing Experimental Design "Emoji" Symbols for Use in Scientific Presentations]]> NIH notices. The purpose of this Request for Information (RFI) is to solicit feedback from the scientific community on the potential utility of creating freely available, simple symbols ("emojis" or icons) to represent various aspects of experimental rigor or design for use in oral and poster presentations.

Responding to this RFI is completely voluntary. Responses may address any or all aspects of the information requested, which is outlined below, or other relevant topics pertinent for consideration by the National Institute of Neurological Disorders and Stroke (NINDS).

 

More information can be found at: https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-014.html

]]> Wed, 22 Nov 2017 09:13:30 -0800